Literature DB >> 33891861

AAV-CNS matters turn from gray to white.

Aaron Mitchell-Dick1, Aravind Asokan2.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33891861      PMCID： PMC8116611          DOI： 10.1016/j.ymthe.2021.04.012

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  13 in total

Review 1.  Gene therapy for neurological disorders: progress and prospects.

Authors:  Benjamin E Deverman; Bernard M Ravina; Krystof S Bankiewicz; Steven M Paul; Dinah W Y Sah
Journal:  Nat Rev Drug Discov       Date:  2018-08-10       Impact factor: 84.694

Review 2.  Therapeutic AAV Gene Transfer to the Nervous System: A Clinical Reality.

Authors:  Eloise Hudry; Luk H Vandenberghe
Journal:  Neuron       Date:  2019-03-06       Impact factor: 17.173

3.  Long-Term Improvement of Neurological Signs and Metabolic Dysfunction in a Mouse Model of Krabbe's Disease after Global Gene Therapy.

Authors:  Michael S Marshall; Yazan Issa; Benas Jakubauskas; Monika Stoskute; Vince Elackattu; Jeffrey N Marshall; Wil Bogue; Duc Nguyen; Zane Hauck; Emily Rue; Subha Karumuthil-Melethil; Violeta Zaric; Maarten Bosland; Richard B van Breemen; Maria I Givogri; Steven J Gray; Stephen J Crocker; Ernesto R Bongarzone
Journal:  Mol Ther       Date:  2018-01-17       Impact factor: 11.454

4.  Intravenous injection of AAVrh10-GALC after the neonatal period in twitcher mice results in significant expression in the central and peripheral nervous systems and improvement of clinical features.

Authors:  Mohammad A Rafi; Han Zhi Rao; Paola Luzi; Alice Luddi; Mark T Curtis; David A Wenger
Journal:  Mol Genet Metab       Date:  2014-12-11       Impact factor: 4.797

5.  Self-renewal and differentiation of reactive astrocyte-derived neural stem/progenitor cells isolated from the cortical peri-infarct area after stroke.

Authors:  Issei S Shimada; Matthew D LeComte; Jerrica C Granger; Noah J Quinlan; Jeffrey L Spees
Journal:  J Neurosci       Date:  2012-06-06       Impact factor: 6.167

6.  Long-term Improvements in Lifespan and Pathology in CNS and PNS After BMT Plus One Intravenous Injection of AAVrh10-GALC in Twitcher Mice.

Authors:  Mohammad A Rafi; Han Zhi Rao; Paola Luzi; David A Wenger
Journal:  Mol Ther       Date:  2015-09-02       Impact factor: 11.454

7.  Neuronal activity promotes oligodendrogenesis and adaptive myelination in the mammalian brain.

Authors:  Erin M Gibson; David Purger; Christopher W Mount; Andrea K Goldstein; Grant L Lin; Lauren S Wood; Ingrid Inema; Sarah E Miller; Gregor Bieri; J Bradley Zuchero; Ben A Barres; Pamelyn J Woo; Hannes Vogel; Michelle Monje
Journal:  Science       Date:  2014-04-10       Impact factor: 47.728

8.  Adeno-Associated Viral Vector (Serotype 2)-Nerve Growth Factor for Patients With Alzheimer Disease: A Randomized Clinical Trial.

Authors:  Michael S Rafii; Mark H Tuszynski; Ronald G Thomas; David Barba; James B Brewer; Robert A Rissman; Joao Siffert; Paul S Aisen
Journal:  JAMA Neurol       Date:  2018-07-01       Impact factor: 18.302

Review 9.  Krabbe disease: genetic aspects and progress toward therapy.

Authors:  D A Wenger; M A Rafi; P Luzi; J Datto; E Costantino-Ceccarini
Journal:  Mol Genet Metab       Date:  2000-05       Impact factor: 4.797

10.  Waning efficacy in a long-term AAV-mediated gene therapy study in the murine model of Krabbe disease.

Authors:  Gregory J Heller; Michael S Marshall; Yazan Issa; Jeffrey N Marshall; Duc Nguyen; Emily Rue; Koralege C Pathmasiri; Miriam S Domowicz; Richard B van Breemen; Leon M Tai; Stephanie M Cologna; Stephen J Crocker; Maria I Givogri; Mark S Sands; Ernesto R Bongarzone
Journal:  Mol Ther       Date:  2021-01-26       Impact factor: 11.454
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.